There is growing evidence that micronutrient intake has a significant effect on the toxicity and carcinogenesis caused by various chemicals. This paper examines the effect of micronutrient status on the toxicity of four nonessential metals: cadmium, lead, mercury, and arsenic. Unfortunately, few studies have directly examined the effect of dietary deficiency or supplementation on metal toxicity. More commonly, the effect of dietary alteration must be deduced from the results of mechanistic studies. We have chosen to separate the effect of micronutrients on toxic metals into three classes: interaction between essential micronutrients and toxic metals during uptake, binding, and excretion; influence of micronutrients on the metabolism of toxic metals; and effect of micronutrients on secondary toxic effects of metals. Based on data from mechanistic studies, the ability of micronutrients to modulate the toxicity of metals is indisputable. Micronutrients interact with toxic metals at several points in the body: absorption and excretion of toxic metals; transport of metals in the body; binding to target proteins; metabolism and sequestration of toxic metals; and finally, in secondary mechanisms of toxicity such as oxidative stress. Therefore, people eating a diet deficient in micronutrients will be predisposed to toxicity from nonessential metals.
Introduction
Research on the effects of micronutrients on toxicity and carcinogenicity caused by various chemicals has produced growing evidence in the field of micronutrient intake and reduction of toxicity. We have reviewed the literature on this topic; however, few studies have directly examined the effect of dietary deficiency or supplementation on metal toxicity. More commonly, the effect of dietary alteration must be deduced from the results of mechanistic studies.
This paper examines the effects of micronutrients on the toxicity of cadmium, lead, mercury, and arsenic -four nonessential metals. The effects of micronutrients on these metals are separated into three classes. The first class deals with the interaction between essential micronutrients and toxic metals during uptake, binding, and excretion. The second class deals with the influence of micronutrients on the metabolism of these toxic metals. The third class describes the effect of micronutrients on secondary effects of metals.
Micronutrients can affect toxicity of metals by interacting with the metal at its primary site of action. Examples of this type of interaction include the effects of calcium on lead, phosphate on arsenate, and zinc on cadmium. In these cases the toxic metal exerts its effect by interfering with the action of the essential compound. By this argument, increasing the availability of the essential micronutrients should decrease the toxicity of toxic metals. More lead is absorbed by people on a calcium-poor diet than by those on a calcium-rich diet.
Micronutrients can also modify the body's response to toxic metals by altering their metabolism and transport. Methionine can prevent methylmercury central nervous system (CNS) toxicity by blocking transport of the methylmercury-cysteine complex into the brain via the large neutral amino acid transporter. Zinc increases synthesis of metallothionein (MT), a thiol-rich protein that sequesters cadmium and prevents acute hepatotoxicity, leading instead to chronic kidney toxicity as cadmium-MT is excreted from the liver and absorbed by the kidney.
Finally, there are a number of other possible interactions of micronutrients with secondary mechanisms of toxicity of nonessential metals. An example of this is the protective effect ofvitamin E on methylmercury toxicity. Vitamin E is an antioxidant and prevents free radical injury caused by methylmercury. Nutrition and Its Effects on Cadmium Toxicity Cadmium, a group IIB metal on the periodic table, is a nonessential trace element. It is present as a contaminant in food (leafy vegetables, grains, and cereals), water, and tobacco leaves, as well as being a byproduct of zinc and lead mining and smelting. Because of its widespread nature, cadmium can either be ingested via contaminated foods or inhaled. Even in small amounts (-200 ppm) significant damage occurs to the kidneys and to the gastrointestinal tract in mammals (1) . Other manifestations of cadmium toxicity include mild anemia and osteoporosis. The most pronounced effects occur in the kidney. Only when significant cadmium damage such as proteinuria and decreased renal function has occurred does significant cadmium excretion occur. Unfortunately, there are few if any symptoms of chronic exposure to small amounts of cadmium. Therefore, by the time symptoms are apparent, hypertension or coronary artery disease may exist in the cadmium-intoxicated patient. Increased cadmium levels are associated with coronary artery disease, hypertension, emphysema, and other chronic pulmonary diseases. This could be the reason cigarette smokers are more prone to acquiring hypertension, coronary artery disease, and emphysema (2) .
The most dangerous characteristic of cadmium is that it accumulates throughout a lifetime. Cadmium accumulates mostly in the liver and kidney and has a long biological half-life of 17 to 30 years in humans. In fact, it has been claimed that approximately one-third of the cadmium accumulated in the body of an adult was absorbed during the first few years of life (3) . A possible explanation of this claim could be the increased amount of milk ingested during infancy. Research has shown that whole-body retention of orally administered '09Cd in rats was about 15 times greater in milk-fed animals than in those receiving normal diets from 3 to 52 weeks of age (4) . Because retention of nonorally administered cadmium was not affected by this diet, it is apparent that a diet consisting entirely of milk influences cadmium metabolism only at the intestinal level. The high absorption in the young may result from pinocytotic absorption of proteins and other macromolecules (5) . The effect of the milk diet could be related to the binding of cadmium to these proteins. Therefore, the increased intestinal absorption of cadmium in the presence of a milk diet is probably attributable to the specific transport ligands present in the milk.
As previously mentioned, cadmium is a nonessential and toxic metal found throughout the environment. Cadmium interacts with the metabolism of four metals essential to nutrition: zinc, iron, calcium, and copper (1, (6) (7) (8) (9) (10) . Table 1 shows major cadmium interactions with these micronutrients and other dietary components. Another important nutritional aspect of cadmium is its interaction with the sulfhydryl-rich protein MT (11, 12) . These and other factors are important in determining the susceptibility of an individual to cadmium toxicity.
Cadmium-Zinc Interactions
Probably one of the most well recognized and well studied metal-metal interactions in the human body is that which occurs between zinc and cadmium. There are many similarities between the two metals. Both cadmium and zinc are members of the group IIB metals. Both metals have a similar tendency to form tetrahedral complexes. Therefore, it seems likely that the two metals would have similar interactions with the human body. Evidence of support for this theory comes from various sources. The sites of absorption for cadmium occur mainly in the duodenum and early jejunum, whereas zinc is absorbed in the jejunum and ileum (13) . Cadmium has an inhibitory effect on the activity of zinc-containing enzymes such as carboxypeptidase (14) and ax-mannosidase (15) . Indeed, cadmium replaces zinc in MT (1) . There are claims of activity reductions of other zinc-containing enzymes that could be pertinent to the toxicity associated with cadmium. Cadmium reduces renal leucine aminopeptidase activity in vivo, an activity that might be responsible for the development of proteinuria (16) .
The toxicity of cadmium may result from disturbances in zinc metabolism, (18) . For example, growth failure (19) , parakeratotic lesions (20) , and impaired glucose tolerance (21) occur in both cases. Cadmium-induced testicular damage arises from competition between cadmium and zinc for binding sites on essential enzymes required for gametogenesis (22) . In rat studies, when dietary zinc is low (5 ppm), pathologic lesions in the liver, lung, heart, and testes were found (23) even though the kidney has been identified as the target organ for cadmium accumulation (24) . In fact, the renal proximal convoluted tubules of Sprague-Dawley rats fed a zinc-deficient diet containing 100 ppm cadmium develop degenerative changes such as cytoplasmic vacuolation, mitochondrial swelling, and coagulative necrosis (25) . Symptoms of cadmium toxicity can be eliminated entirely by using a zinc supplement. This finding further demonstrates the antagonism between zinc and cadmium. The pathologic lesions caused by cadmium found in the liver, lung, heart, and testes of zinc-deficient rats can be dispelled when a 40-ppm zinc supplement is administered. Cadmium toxicity has also been reversed in chicks given zinc supplements (26) . Zinc supplements are important during the last two trimesters of pregnancy because a significant decrease in plasma zinc levels has been observed in nonoccupationally cadmium-exposed women in southern Catalonia, Spain (27) . The testicular necrosis described previously can be prevented by injection with zinc prior to cadmium exposure. Also, the ratio of zinc to cadmium concentrations is important in determining whether an industrial worker is susceptible to hypertension and/or coronary artery disease (28) . The most compelling reason for the protective effects of zinc against cadmium toxicity is that zinc induces the production of the metal-binding protein MT (29). This cadmium-binding protein will be discussed later.
Cadmium-Iron Interactions
One of the symptoms associated with cadmium intoxication is the development of anemia in the exposed individual, a result of the inhibitory effect of cadmium on iron metabolism and absorption. Cadmium decreases hematocrit and hemoglobin levels in exposed workers. Rats receiving a diet (41) . The main physiologic role of MT is to act as a homeostatic control mechanism by controlling the metabolism of both copper and zinc. Therefore, binding of a nonessential metal such as cadmium to MT is a fortuitous result of the chemical similarity between cadmium and the essential trace metals. Cadmium has a higher affinity for MT and in fact displaces zinc from the cysteine binding sites but does not displace copper because this essential trace metal has higher MT affinity (39). The free essential trace metals could then stimulate the production of more MT or be excreted in the urine, which would explain the deficiencies in these two metals observed during cadmium exposure. Zinc and copper supplements are thought to act by inducing MT synthesis, which allows the body to be adequately supplied with enough MT to combat the cadmium insult.
Even though MT offers mostly protective effects against cadmium toxicity, there is evidence that it is indirectly involved in contributing to cadmium's main toxic effect: renal failure. In the urine of cadmium-dosed animals, a large amount of cadmium-MT complex was recovered, indicating that the kidney is not very efficient at MT reabsorption (42). This complex is somewhat retained by the kidney and the protein is rapidly degraded, leaving free cadmium to accumulate in the kidneys. Therefore, MT is the vehicle that transports cadmium to its toxic site ofaction, the kidney.
Other Cadmium-Nutrient Interactions
A low-protein diet also makes one more susceptible to cadmium toxicity. Feeding experimental animals a low-protein diet before cadmium administration results in increased cadmium uptake by the whole body, which leads to decreased growth and increased bone deformities (43). Another predisposing factor is that protein production decreases; in other words synthesis of MT, the primary cadmium detoxification protein, occurs at a much lower rate.
Nutritional studies have shown that selenium offers some protection against acute cadmium-induced toxicity. The protective effects of selenium probably come into play by the shifting of cadmium binding from MT to higher molecular-weight proteins (44). This allows MT to be unencumbered and therefore able to bind essential nutrients such as zinc and copper.
Studies also have been conducted on the effect of vitamins on cadmium toxicity. Although the exact mechanism is unknown, Environmental Health Perspectives * Vol 106, Supplement 1 * February 1998 vitamin C supplementation reduces elevated cadmium levels in the kidneys and livers of pigs fed a copper-rich diet (40). The addition of microbial phytase counteracted the decrease in growth and zinc status brought on by phytic acid and cadmium. Phytase also lowered liver and kidney cadmium concentrations (45). A significant attenuation of cadmium-induced tissue injury was observed in retinol-pretreated rats, possibly because of a 7-fold increase in MT production in the liver and less cadmium accumulation in the lung, kidney, and testis (46) .
Nutrition and Its Effects on Lead Toxicity
Lead causes many adverse health affects, including toxicity of the nervous, hematopoietic, renal, endocrine, and skeletal systems, with the CNS as the primary target organ. Presently, impairment of cognitive and behavioral development in infants and young children is the toxic effect of greatest concern.
Toxicity, which is both age and lead dose dependent, occurs from low-level exposures from various environmental sources including air, food, and water. However, removal of leaded gasoline in the United States and other countries and elimination of lead-soldered cans in the canning of food products greatly reduced the extent of exposure from these sources. Lead-containing paint, used in older homes built before the 1970s or in urban, lower-income housing, is a major source of lead exposure for young children. These children may sustain many of the risk factors such as low socioeconomic status and calcium and iron insufficiencies known to intensify the manifestations of lead exposure. Lead toxicity, including its effects on the CNS, is known to occur with blood concentrations between 0.48 and 0.72 pmol/liter, and over 1 million children in the United States have blood concentrations in this range or higher (47, 48) . In the adult subpopulation, physiologic conditions associated with bone resorption, including pregnancy, lactation, and aging, can also potentiate the CNS effects of lead and enhance exposure.
Calcium supplements, wine, leaded crystal glass, and lead-containing glazed pottery are additional sources of lead exposure (49, 50) . Imported ceramics from Mexico, China, Korea, Italy, and Spain can release large amounts of lead into food and drink (51) . Contamination from this pottery is now a leading public health problem in Mexico (52) . Numerous studies have shown that the lead content of glazed ceramics used to prepare and store food is a major predictor of blood lead levels in Mexico, especially in children (53, 54) .
Lead-Calcium Interactions
Extensive clinical and experimental evidence supports the significance of lead-calcium interactions (55) . These interactions occur at the cellular and molecular levels and are a result of the ability of lead to mimic or displace calcium during specific physiologic processes. Studies show that lead inhibits the release of neurotransmitters by blocking the entry of calcium into nerve terminals (56, 57) , by competing with calcium for uptake by calcium channels (58, 59) , and by inhibiting all subtypes of calcium channels (60) (61) (62) . It is likely that lead blocks calcium efflux from cells by substituting for calcium in Ca2+/Na+ adenosine triphosphate (ATP) pumps. This mechanism of interference could possibly explain how lead interacts with calcium in the intestine (63, 64) . Another critical interaction between lead and calcium occurs within cells, where lead interferes with calcium binding to receptors coupled with second messenger functions (65) (66) (67) . This mechanism involves a competition between lead and calcium for calcium receptor proteins like calmodulin and protein kinase C (PKC). Lead acts by displacing the calcium bound to calmodulin and affecting the free concentration of calcium inside the nerve terminal, which leads to the stimulation of neurotransmitter release (67) (68) (69) . Lead appears to have a better capacity to activate PKC, thus causing an increase in its activity. This can lead to increases in cell division and proliferation and increases in cellular responses to PKC such as cell-cell communications, cytoskeletal organization, and the release of neurotransmitters (67, (69) (70) (71) . Recent evidence also shows that lead alters inositol polyphosphate receptor binding in the rat brain, possibly resulting in altered intracellular calcium levels that may influence neuronal activity (72) . Evidence for all these interactions suggests that leadinduced disruption of calcium homeostasis in the immature and developing brain may interfere with normal development (73) .
Calcium Effects on Lead Absorption
Gastrointestinal lead absorption and retention constitutes the major pathway of lead intake (74) and depends on the micronutrient status of the gastrointestinal lumen. Adults absorb approximately 10% of ingested lead and small children absorb approximately 50% of ingested lead. This difference may be the result of a higher density of intestinal transport proteins during periods of high growth (75) .
Absorbed lead enters the blood and reaches the bones and soft tissues of the body, including the liver, from which it is gradually excreted (76) . Long-term studies indicate that lead is not excreted at the same rate as it is absorbed (77, 78) . Lead, which is excreted both in urine and feces, continuously accumulates in the body tissues with age.
Nutritional factors are thought to play an important role in lead poisoning. Enhanced susceptibility to lead intoxication in cases of dietary calcium deficiency has been attributed to increased intestinal absorption (79) and body lead retention (80) . Calcium and lead compete for similar binding sites on intestinal mucosal proteins, which are important in the absorptive process (81) . These shared binding sites on absorptive proteins would explain why sufficient dietary calcium decreases lead absorption. A study by Six and Goyer (80) has shown that rats fed a low-calcium diet containing varying amounts of lead had higher blood and tissue concentrations of lead than rats fed a normal-calcium diet. This study demonstrates that dietary calcium deficiency increases lead concentration in critical organs.
Other studies have also shown that absorption of lead by the gastrointestinal tract is inversely related to dietary calcium. A study of pregnant women in Mexico City (82) found that use of lead-glazed ceramics was associated with elevated blood lead levels and that consumption of tortillas (rich in calcium) lowered blood lead levels in women of lower socioeconomic status. This decrease was not significant, but consumption of milk products significantly decreased blood lead levels in women of higher socioeconomic status.
Studies on the effect of a dietary excess of calcium on lead toxicity (83) (84) (85) indicate that a small decrease in lead absorption and blood concentration can be achieved; however, this effect is not as dramatic as the effect of calcium insufficiency on lead uptake and retention. Therefore the achievement of adequate rather than excessive dietary calcium seems to be more useful in combating lead intoxication.
Iead and Bone Metabolism
More than 95% of the adult body burden of lead is in the bone (86) . Therefore bone Environmental Health Perspectives * Vol 106, Supplement 1 * February 1998 metabolism plays as important a role as do absorption and excretion in the ultimate fate of lead in the human body (87) .
Reviews on the influences of calcium, phosphorous, and vitamin D on the uptake of lead by bone are extensive (75, 86, 88, 89) . A study of postpartum women in Mexico City (90) determined that use of lead-glazed ceramic ware along with lower consumption of high calcium-containing foods contributed significantly to higher bone retention of lead. Studies in rats also show that a phosphorous-deficient diet increases lead retention and that calcium-and phosphorous-deficient diets have an additive effect on lead retention (91) . Thus, evidence suggests that dietary calcium and phosphorous sufficiencies can have an additive inhibitory effect on the absorption and retention of lead (92, 93) .
Vitamin D not only increases intestinal calcium and phosphate absorption but also stimulates the coabsorption of other essential minerals like magnesium, iron, and zinc and the absorption of toxic metals such as lead (88, (94) (95) (96) . One effect of vitamin D that may be involved in increased intestinal absorption of lead is the induction of calcium-binding proteins by intestinal cells (97) . Studies show that leadbinding properties of these calcium-binding proteins could indeed result in vitamin D enhancement of lead absorption and deposition in both the kidney and bone (98) . Furthermore, when calcium levels are low, serum levels of the vitamin D hormone, 1,25-dihydroxy-vitamin D, are elevated to stimulate intestinal absorption of calcium and synthesis of calbindin-D, a calciumbinding protein (99) . Thus, this provides another mechanism by which lead absorption could increase in times of calcium deficiency (79, 97) .
Following deposition in the bone, lead can be mobilized in response to both physiologic and pathologic conditions. Mobilization of long-term stores of lead from the maternal skeleton may be a major determinant in transfer of lead from mother to infant during pregnancy and lactation. Studies in rats indicate that lead stored in bone as a result of previous maternal exposure should be considered a major source of self intoxication and milk contamination in lactating mothers (100) . A study in Sweden found a decrease in serum calcium levels and an increase in blood lead concentrations in pregnant women, possibly because of mobilization of lead from bone (101) . After onset of menopause there can be a marked mobilization of calcium from bone and hormone replacement therapy may reduce the return of endogenous lead to the circulation (102) . Lead-Iron Interactions Nutritional iron deficiency and iron deficiency during periods of rapid growth, such as infancy, in laboratory animals also enhances lead absorption and promotes lead toxicity. This is more evidence for concern that pregnant women and young children may be more susceptible to dietary lead (103) . However, unlike calcium deficiency, iron deficiency in rodents does not appear to result in redistribution of lead to nonbone tissues (104); it only affects the gastrointestinal absorption of lead (105) . A negative relationship between dietary iron intake and blood lead levels was also found in a study of preschool children (106) . Iron deficiency is recognized worldwide as one of the most prevalent nutritional problems; impairment of cognitive function among iron-deficient children has also been recognized (107, 108) . However, the mechanism by which iron deficiency is associated with behavioral alterations is not dear.
The effects of lead and iron on the heme biosynthetic pathways have been extensively investigated and characterized. Lead inhibits two major enzymes of the heme biosynthetic pathway: delta-aminolevulinic acid dehydratase (&-ALAD) and ferrochelatase. Furthermore, lead seems to raise deltaaminolevulinic acid (&-ALA) synthase activity, which leads to an accumulation of 6-ALA (109, 110) . Lead interferes with mitochondrial energy metabolism, which is necessary to reduce ferric iron to ferrous iron before insertion of iron into the porphyrin ring. When iron deficiency is present, ferrochelatase is more sensitive to these effects of lead (110) 
Mercury-elenium Interacdons
Selenium was discovered in 1817 by Jon Jakob Berzelius (145) . It is a nonmetal with some metallic characteristics and it occurs in nature as selenides of lead, copper, mercury, and silver. Selenium is a required dietary element for health, but it is also a toxic material. Required selenium levels for good health are between 0.04 and 0.1 ppm (145) . In general, levels of selenium of 5 to 10 mg/kg of food are considered toxic (146) . The naturally occurring levels of selenium in foods are capable of modifying methylmercury toxicity (147) . The first study reporting that selenium counteracted acute mercuric chloride toxicity was published in 1969 (148) . At that time selenium was reported to be highly effective in treating chronic methylmercury toxicity (149) . The concentration of selenium used (5 ppm) was below the recommended concentration of dietary selenium in contrast to the concentration of selenium needed to protect against inorganic mercury (around 40 ppm), which is above the nutritional range.
Selenium's mechanisms of protection against methylmercury and inorganic mercury may be different. Selenium protection against inorganic mercury may involve a variety of mechanisms such as the direct stoichiometric complexing of mercury to reduce its availability (150) . The There may also be another protective mechanism involving selenium. When methylmercury is degraded to inorganic mercury, the methyl moiety can also be further degraded by homolysis to methyl free radicals (148) . These molecules may initiate a chain reaction peroxidation of various lipid constituents. These products result as part of the metal toxicity. Seleniumdependent glutathione (GSH) peroxidase protects the cells by catalyzing the reduction of hydrogen peroxide and other organic hydroperoxides to products of greater stability (152) .
Mercury-Vitamin E Interacdons
Vitamin E was first reported to protect against methylmercury toxicity in 1974 and it was shown that high levels of vitamin E decreased mortality in Japanese quail fed 30 ppm methylmercury (153) . The mechanism of action of vitamin E is that of a scavenger of radicals that otherwise initiate methylmercury breakdown. Vitamin E also can react with methyl radicals that might be formed in the breakdown. Other antioxidants may then be expected to protect against not only mercury but also other metal-induced toxicities. However, the most effective action of vitamin E may be related to its location in the cell membranes (a result of its physicochemical properties) and to its ability to stabilize membranes by interacting with unsaturated fatty acid chains (148) .
Other Mercury Interacdons
Hydrogen peroxide contributes to the cytotoxicity of mercuric chloride in vivo and in vitro. The nonenzymatic scavenger for hydrogen peroxide, pyruvate, and the enzymatic scavenger, catalase, reduce mercuryinduced cell injury (124) . Methylmercury neurotoxicity is blocked by other oxygen radical scavengers such as GSH, catalase, and cysteine (126) . Methionine also affects mercury toxicity (154) . Methionine supplementation depresses methylmercuryinduced weight loss and liver weight, depresses deposition of mercury, and prevents depression of blood GSH peroxidase in rats (154) . Mercury (155) . MT-III is present only in the brain, primarily in neurons, and seemingly is not inducible (155) . A summary of interactions with micronutrients and other dietary components can be found in Table 3 .
Responses to Mercury Toxicity
One of the toxic effects of mercury is oxidativelike toxicity. The exposure of tissues to oxidative stress often instigates an antioxidant response that defends against or limits the severity of the oxidative injury. The activity of the hydrogen-peroxide degrading enzyme, GSH peroxidase, is decreased after exposure to mercury, which may contribute to increased renal generation of hydrogen peroxide. Another enzyme, heme oxygenase, is markedly induced by mercury in the kidney at early time points and may indicate a protective response (124) . As a possible antioxidant response, the members of the bcl genes, bc12 and bcl, are induced by mercury in the kidney (124) . These genes protect against apoptotic cell death. The bc2 gene is efficacious against oxidant-induced cell damage and prevents cell death induced by GSH depletion and the resulting oxidative stress and lipid peroxidation (124) . The bclx gene is induced 16 hr after mercury treatment in conjunction with bc12 and also protects against oxidant-induced cell death. The cellular site of expression of these two genes (bcI2 mainly, bclx exclusively) is the cell mitochondria, which is significantly altered by mercury (124) . The induction of these two genes may represent a cytoprotective response that may be particularly salutary to the mitochondrion.
Nutrition and Its Effects on Arsenic Toxicity
Arsenic is a naturally occurring element. Most exposure is through consumption of food and water. Although the mechanism of chronic arsenic toxicity is not known, studies of populations in Taiwan (156) , Chile (157, 158) , and Mexico (159) (163) , arsenite interacts with thiols and affects many functional proteins (164) . As reviewed by Thompson (165) , inorganic arsenic in the body is methylated by methyltransferase using S-adenosylmethionine as the methyl donor. The methylated forms monomethylarsonic acid (MMA) and dimethylarsenic acid (DMA) are less toxic, have lower affinities for tissue constituents, and are excreted in the urine, thus making methylation a detoxification reaction. Ingestion of arsenic already in an organic form, such as arsenobetaine (a common contaminant in marine fish from the bioaccumulation of microbiologically unchanged into the urine (166) . The order of toxicity of arsenic species in mammals appears to be As(III), As(V), MMA, DMA, then other organic arsenic.
Direct studies on the effects of nutrition on arsenic toxicity have been hindered by lack of an adequate animal model of chronic arsenic toxicity and carcinogenicity. Populations exhibiting arsenic toxicity have mainly been of low economic status and suffering from some form of malnutrition. Nutritional studies in Chile revealed food energy and total protein intakes below recommended daily allowances (167 (163, 173) . That phosphate and arsenate can share the same transport mechanism is indicated by the decrease in intestinal absorption of arsenic with phosphate infusion in the rat (174) . Theoretically, dietary phosphate could outcompete arsenate uptake and decrease toxicity. Whereas phosphate loading has been used by some athletes to enhance performance (175) , the use of this supplement to ameliorate arsenate toxicity has not been studied. Phosphorus is so abundant in natural foods that phosphorus deficiency almost never occurs naturally.
The chemical similarity between arsenic and selenium, an essential micronutrient, generally allows for antagonistic effects between these two metalloids (176); however, there seems to be synergistic toxicity between arsenic and methylated selenium species (177) . Unlike with phosphate, there is no interaction between arsenic and selenium gastrointestinal absorption (178) . Instead, selenium and arsenic each increase the biliary excretion of the other (179) . Arsenic appears to abolish the anticarcinogenic effects of selenium (180) but can actually be therapeutic in alleviating Interaction and mechanism Effect of nutrient on metal toxicity As-selenium Antagonistic effects Decreases teratogenic toxicity As-cysteine Sulfur-amino acid content affects GSH GSH detoxifies As As-methionine levels; As binds thiol groups As-protein As-methionine Precursors of S-adenosyl methionine, Important for As detoxification As-choline which is used in methylation of As As-protein As-zinc Mechanism unknown Zinc pretreatment associated with increased As elimination As-vitamin E Antioxidants scavenge oxygen radicals Decreases damage to macroAs-vitamin A formed during As metabolism molecules and decreases chance of developing lung cancer As-garlic extracts As binds to sulfur moieties of garlic (186) . Low sulfur amino acid content of the diet (i.e., cysteine or methionine) or more generally, low-protein diets, yield low GSH levels and more pronounced arsenite-induced cellular toxicity (187) .
Effects ofDiet on Arsenic Metabolism A low-protein diet can aggravate toxicity in another way. Low dietary intake of methionine, choline, or proteins decreased arsenic excretion (especially urinary excretion of DMA) and increased the tissue retention of arsenic in rabbits (188) . Diets deficient in methionine and choline decrease S-adenosylmethionine levels, therefore inhibiting methyltransferase reactions (189) , i.e., arsenic detoxification reactions.
Arsenic can induce increases in MT levels (190) , which implies that arsenic can be detoxified by this low-molecular-weight, cysteine-rich, metal-binding protein. Zinc- induced increases in MT, however, do not seem to be responsible for the protection against arsenic lethality in mice pretreated with zinc (191) . Although the mechanism for this tolerance to arsenic toxicity is not known, zinc pretreatment was associated with increased elimination of arsenic.
Effects ofDiet on Secondary Arsenic Toxic Effects
During arsenic metabolism oxygen radicals may be produced, possibly leading to damage of DNA, proteins, lipids, and other molecules. There is a positive correlation between lipid peroxidation and arsenic tissue concentrations in the livers, kidneys, and hearts of arsenite-treated rats (192) . Arsenite induces the body's antioxidant activities in human fibroblasts (193) . Arsenite induces heme oxygenase, leading to heme degradation, iron release, and decreases in the cytochrome P450 biotransformation enzymes important in both endogenous and xenobiotic metabolism (194) . Superoxide dismutase activity was also increased by sodium arsenite treatment in human fibroblasts (193) . Dietary antioxidants such as vitamins E and A may also alleviate arsenic toxicity. Addition of vitamin E could at least in part prevent the arsenite-induced killing of human fibroblasts (195) . As mentioned previously a role for vitamin A deficiency in the expression of arsenic toxicity has been implied by the nutrition survey comparison between populations in Mexico and California (172) . Dietary intake of fruits and vegetables, particularly yellow and light green vegetables (foods high in vitamin A precursors), was inversely associated with the odds ratio of lung cancer in tin miners exposed to arsenic and other risk factors (196) .
Because of arsenic's affinity for protein sulfhydryls, many side effects can occur from enzyme inhibition. Chronic arsenite toxicity results in mitochondrial changes that block lipoic acid-dependent dehydrogenase, which in turn inhibits glycolysis and results in a demand for glucose and subsequently in hypoglycemia (197) . Arsenicals also inhibit pyruvate dehydrogenase in gluconeogenesis (198) . Carbohydrate depletion caused by gluconeogenesis depletion may therefore aggravate arsenic poisoning. Studies show starved rats were more sensitive to As(III) than rats with free access to food (198) , although starvation would also affect other potentially important dietary factors. Inhibition of citric acid cycle enzymes and associated reactions in the P cells of mice appears to induce features of diabetes (199) . It has been suggested that arsenic exposure may play a role in the development of diabetes mellitus because there is an association of the disease with arsenic in drinking water in Taiwan (200) and with arsenic from occupational exposure in copper smelter employees in Sweden (201) .
Dietary supplements may also affect arsenic toxicity and carcinogenicity. Arseniteinduced bone marrow chromosomal aberrations were decreased in mice fed crude garlic extracts (202 Because studies of these highly exposed populations from developing countries are the basis for setting regulatory levels in other countries, the role of nutritional status on the effects of arsenic cannot be overlooked. More research is needed to determine which dietary factors may alleviate or exacerbate arsenic toxicity. Whether remediation of dietary deficiencies will be enough to handle the arsenic burden or whether nutrient levels above the recommended daily allowances will be necessary remains to be determined.
Conclusions
There have not been many studies designed specifically to address the effect of micronutrient status on toxicity from exposure to nonessential metals. Based on data from mechanistic studies, the ability of micronutrients to modulate the toxicity of metals is indisputable. Micronutrients interact with toxic metals at several points in the body: absorption and excretion of toxic metals; transport of metals in the body; binding to target proteins; metabolism and sequestration of toxic metals; and finally, in secondary mechanisms of toxicity (such as oxidative stress). Therefore, people eating a diet deficient in micronutrients will be predisposed to toxicity from nonessential metals.
The fact that dietary sufficiency can have a significant impact on toxicity of nonessential metals may greatly affect risk assessment for these metals. Epidemiologic studies used to set acceptable exposure levels for nonessential metals in the United States have been performed in other countries. The diets of individuals in these countries are far different from diets in the United States. Depending on the micronutrient content of the diet, toxicity may be significantly different in other countries than in the United States. An example is the development of Itai-Itai disease in calcium-deficient Japanese individuals exposed to cadmium. Studies that determine the impact of diet on toxicity will make risk assessment more accurate.
The possibilities provided by the interaction ofdiet with toxic metals are clear. We can no longer afford to ignore the effect of micronutrients on the health of humans and animals exposed to toxic metals. The typical remedy for toxic metal exposure has been to remove the exposure source. However, situations such as the arsenicism in India today will arise-situations in which millions of people are affected and it is impossible to remove everyone from exposure. In these cases dietary manipulation may provide the best defense and must be understood to be of use. 
